Reinventing Biotech’s Business Model: The Photo Gallery

NEXT IMAGE >>
Reinventing Biotech’s Business Model— Cliff Stocks, the CEO of Theraclone Sciences (left) talked about incorporating some of the business lessons learned from two very different models at his past companies, Icos and Calistoga Pharmaceuticals. On the right is Alex Lash of Startup magazine, who moderated the second half of afternoon chats.
Photo by Luke Timmerman

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.